Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
12/05/2007 | EP1862542A1 Detecting chip and method of detecting substance using the same |
12/05/2007 | EP1862541A1 Polypeptides derived from the hemopexin-like domain of metalloproteinase MMP-2 |
12/05/2007 | EP1862538A1 siRNA kinase and methods of use |
12/05/2007 | EP1862536A1 Microorganism capable of accumulating ultra high molecular weight polyester |
12/05/2007 | EP1862475A1 Polymer conjugates of neublastin and methods of using same |
12/05/2007 | EP1862474A1 Reagent for the diagnosis of rheumatoid arthritis |
12/05/2007 | EP1862473A2 Corn root preferential promoters and uses thereof |
12/05/2007 | EP1862472A2 Chlamydia protein, gene sequence and uses thereof |
12/05/2007 | EP1861506A2 Cellulases, nucleic acids encoding them and methods for making and using them |
12/05/2007 | EP1861501A2 Reducing levels of nicotinic alkaloids in plants |
12/05/2007 | EP1861500A2 Expression vectors and methods for obtaining nk cell specific expression |
12/05/2007 | EP1861499A1 Methods and compositions for producing active vitamin k-dependent proteins |
12/05/2007 | EP1861498A2 Expression vectors for enhanced transient gene expression and mammalian cells expressing them |
12/05/2007 | EP1861497A1 Protein and its use in diagnosing alzheimer's disease |
12/05/2007 | EP1861496A2 Inhibition of spag9 expression with sirnas |
12/05/2007 | EP1861495A1 Use of nucleases for degrading nucleic acids in the presence of chaotropic agents and/or surfactants |
12/05/2007 | EP1861494A1 Recombinant protein comprising starch binding domain and use thereof |
12/05/2007 | EP1861491A1 Flavivirus replicon constructs for tumour therapy |
12/05/2007 | EP1861420A1 Fermentation process for the production of diphtheria toxin |
12/05/2007 | EP1861418A2 T cd4+ epitopes of type i and ii latency antigens of the epstein-barr virus, which can be recognised by the majority of individuals in the caucasian population and applications thereof |
12/05/2007 | EP1861417A2 Dimeric or multimeric microproteins |
12/05/2007 | EP1861108A1 Antimicrobial compounds |
12/05/2007 | EP1860932A2 A root-preferred, nematode-inducible soybean promoter and its use |
12/05/2007 | EP1670415A4 Animal model for protease activity and liver damage |
12/05/2007 | EP1664295A4 Method for isolating and purifying a nucleic acid |
12/05/2007 | EP1613730A4 Novel plant promoters for use in early seed development |
12/05/2007 | EP1583417A4 Elevation of oil levels in brassica plants |
12/05/2007 | EP1497411A4 Embryo modification and implantation |
12/05/2007 | EP1492876B1 Cationic amphiphiles for intracellular delivery of therapeutic molecules, composition, process and use thereof |
12/05/2007 | EP1434483B1 Nucleic acids encoding linked chromo/fluorescent domains and methods for using the same |
12/05/2007 | EP1335986B1 Phosphatase stress-related protein and methods of use in plants |
12/05/2007 | EP1305399B1 Bacillus subtilis var. chungkookjang producing high molecular weight poly-gamma-glutamic acid |
12/05/2007 | EP1303621B1 Novel cacao endoproteinases and their use in the production of cocoa flavour |
12/05/2007 | EP1263752B1 Lpa receptor agonists and antagonists and methods of use |
12/05/2007 | EP1228198B1 Method for modulating nitrilase selectivity, nitrilases obtained by said method and use thereof |
12/05/2007 | EP1223976B1 Novel process for making human papillomavirus virus-like particles with improved properties |
12/05/2007 | EP1222207B1 C-peptide for the improved production of insulin and insulin analogues |
12/05/2007 | EP1144610B1 Method for carrying out the controlled post-harvest production of proteins in plants |
12/05/2007 | EP1141358B1 STABLY TRANSFECTED CELLS FOR IDENTIFYING COMPOUNDS WHICH AFFECT STABILITY OF mRNA |
12/05/2007 | EP1141355B1 S-adenosyl-l-methionine synthetase promoter and its use in expression of transgenic genes in plants |
12/05/2007 | EP1010761B1 Gene of alteromonas |
12/05/2007 | EP0941252B1 Anti-p53 single-chain antibody fragments and their uses |
12/05/2007 | EP0932418B1 Method for recombinant adeno-associated virus-directed gene therapy |
12/05/2007 | EP0931149B1 A novel haemopoietin receptor and genetic sequences encoding same |
12/05/2007 | EP0760675B2 Compositions comprising dna damaging agents and p53 |
12/05/2007 | EP0708831B2 Cell-density enhanced protein tyrosine phosphatases |
12/05/2007 | CN101084509A Methods of identifying and designing cell surface receptor inhibitors |
12/05/2007 | CN101084317A Suppression of endogenous immunoglobulin expression |
12/05/2007 | CN101084316A Generation of plants with altered oil content |
12/05/2007 | CN101084315A Sugarcane plants with an increased storage carbohydrate content |
12/05/2007 | CN101084314A Lactobacillus acidophilus nucleic acids and uses thereof |
12/05/2007 | CN101084313A Method for preparing transformants expressing benzaldehyde dehydrogenase and prepation of 2,6-naphthalene dicarboxylic acid using the transformants |
12/05/2007 | CN101084312A Mutant of the proB gene from coryneform bacteria |
12/05/2007 | CN101084311A Biosynthesis of phloroglucinol and preparation of 1,3-dihydroxybenzene therefrom |
12/05/2007 | CN101084310A Semi-soft c-class immunostimulatory oligonucleotides |
12/05/2007 | CN101084309A Neuron regeneration |
12/05/2007 | CN101084306A Overexpressed and purified aspergillus ficuum oxidase and nucleic acid encoding the same |
12/05/2007 | CN101084302A Recombinant microorganism |
12/05/2007 | CN101084238A Receptor selectivity lymphotoxin derivates |
12/05/2007 | CN101084237A Ubiquitin or gamma-crystalline conjugates for use in therapy, diagnosis and chromatography |
12/05/2007 | CN101084233A Methods for reducing or eliminating alpha-mannosidase resistant glycans for the production of glycoproteins |
12/05/2007 | CN101082051A Recombined foot-and-mouth disease virus polypeptide fragment and and uses thereof |
12/05/2007 | CN101082050A Corynebacterium glutamicum genes encoding proteins involved in membrane synthesis and membrane transport |
12/05/2007 | CN101082049A Corynebacterium glutamicum genes encoding proteins involved in membrane synthesis and membrane transport |
12/05/2007 | CN101082048A Sweetpotato expansin cDNA and high-yield transgenic plants using the same |
12/05/2007 | CN101082047A Beta-glucosidase gene promoter and uses thereof |
12/05/2007 | CN101082046A Heterogenetic expression method for recombined pea albumin subfraction PA1b gene |
12/05/2007 | CN101082045A Preparation method of apolipoprotein-J |
12/05/2007 | CN101082042A Application of artificial reconstructed defect type human 3-type adenovirus |
12/05/2007 | CN101082041A Novel vaccinia virus strain, vaccinia live attenuated vaccine and preparation method thereof |
12/05/2007 | CN101081871A Protein transduction field 4-apopain fusion protein (PTD4-Apoptin) and preparation method and application thereof |
12/05/2007 | CN101081870A Antineoplastic biological medicament PTD4-GFP-Apoptin fusion protein and preparation method thereof |
12/05/2007 | CN101081869A Humanized antibodies that recognize beta amyloid peptide |
12/05/2007 | CN101081868A Humanized antibodies that recognize beta amyloid peptide |
12/05/2007 | CN101081867A Humanized antibodies that recognize beta amyloid peptide |
12/05/2007 | CN101081864A A plurality of reconstructing antibiotic peptide and preparation method and application thereof |
12/05/2007 | CN101081863A Lipopolysaccharide conjugated protein and monoclonal antibody and preparation method and usage |
12/05/2007 | CN100352942C A microarray having microarray identification information stored in the form of a spot. method of producing the microarray and method of using the microarray |
12/05/2007 | CN100352940C DNA amplification method and kit therefor |
12/05/2007 | CN100352939C Methods for detecting DNA originating from different individuals |
12/05/2007 | CN100352935C Method for producing dipeptide |
12/05/2007 | CN100352933C Degradation of hydrophobic esters pesticide and toxins |
12/05/2007 | CN100352932C Novel enzymes which dehydrate glycerol |
12/05/2007 | CN100352930C Vaccines immunotherapeutics and method for using the same |
12/05/2007 | CN100352929C Bitarget fibroblast growth factor acceptor and transgene carrier of integrated element |
12/05/2007 | CN100352928C Production of L phenylalanine gene engineering bacteria and construction method and its application |
12/05/2007 | CN100352927C Model for neurodegenerative disease |
12/05/2007 | CN100352926C Nucleotide sequences which code for the opc A gene |
12/05/2007 | CN100352925C RNP originating in paramyxovirus |
12/05/2007 | CN100352924C BASB 111 polypeptide and polynucleotide from moraxella cathraahalis |
12/05/2007 | CN100352923C Nucleic acids, polypeptides, and methods for modulating apoptosis |
12/05/2007 | CN100352922C SiRAN and expression carrier for inhibiting human VEGF gene expression and their pharmaceutical use |
12/05/2007 | CN100352921C Compositions and methods for identifying antigens which elicit an immune response |
12/05/2007 | CN100352920C Non-reducing saccharide-forming enzyme, and its preparation and uses |
12/05/2007 | CN100352919C Glyphosate resistant class i 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS) |
12/05/2007 | CN100352844C Recombinant anti-osteopontin antibody and use thereof |
12/05/2007 | CN100352843C Kdr peptides and vaccines comprising the same |
12/05/2007 | CN100352842C Genes whose expression is increased in response to stimulation by corticotropin-releasing hormone |
12/05/2007 | CN100352841C Antibiotic peptide and its coding sequence and uses |
12/05/2007 | CN100352838C Interfusion protein of antineoplastic genetic engineering composed of target short peptide of receptor of epidermal growth factor and Lidamycin |